MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on BlueRx Enhanced Plus (S1030-001)

Biktarvy, Dovato, Descovy and the other common HIV regimens, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Alabama + 1 more
Premium
$129.50/month
Deductible
$150.00, doesn't apply to tier 1 and 2
Change plan

10 of 11 HIV drugs are covered on this plan. None require prior authorization.

1 isn't on the formulary (Truvada).

  • Biktarvy
    bictegravir/emtricitabine/tenofovir alafenamide
    Covered
    from $1,354.93
    Tier 5
  • Dovato
    dolutegravir and lamivudine
    Covered
    $1,016.96
    Tier 5
  • Triumeq
    abacavir/dolutegravir/lamivudine
    Covered
    from $1,071.63
    Tier 4
  • Genvoya
    elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
    Covered
    $1,406.20
    Tier 5
  • Odefsey
    emtricitabine/rilpivirine/tenofovir alafenamide
    Covered
    $1,279.26
    Tier 5
  • Symtuza
    darunavir/cobicistat/emtricitabine/tenofovir alafenamide
    Covered
    $1,463.58
    Tier 5
  • Juluca
    dolutegravir and rilpivirine
    Covered
    $1,181.37
    Tier 5
  • Descovy
    emtricitabine and tenofovir alafenamide
    Covered
    from $744.59
    Tier 5
  • emtricitabine-tenofovir
    generic Truvada
    Covered
    from $15.46
    Tier 4
  • Tivicay
    dolutegravir
    Covered
    from $931.37
    Tier 5
Not on the formulary
Truvada

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $150.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list